SHARE THIS PAGE:
Children’s National Hospital – Congenital Infection Program has launched a pilot study being led by Sarah Mulkey, MD, PhD, “Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure.” […]
JAMA (Yang, Y., et al. )10. 24. 2023 published an original investigation “Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.” Investigators of this clinical study conducted a randomized, double-blind, placebo-controlled clinical trial of 3777 patients with acute ST-segment elevation myocardial infarction (STEMI). Patients from 124 hospitals in China presenting with STEMI between May-December 2020 were given either oral Tongxinluo or placebo within 24 hours of symptom onset. The adjunctive treatment or placebo was administered for 12 months, and positive patient outcome was observed.
You are invited to join Sarah Mulkey, M.D., Ph.D. to learn about a new study at Children’s National Hospital on the effects of Lyme disease on pregnancy and early neurodevelopmental outcomes. Held on Zoom, May 3rd – Free – 7PM
Columbia University Irving Medical Center’s Clinical Trials Network (CTN) for Lyme and Other Tick-Borne Diseases, established with a grant from the Steven & Alexandra Cohen Foundation to Columbia University, has announced the third round of Pilot Study Proposal submissions. Clinicians, researchers, and investigators from educational institutions are welcome to submit proposals.
Johns Hopkins Center for Psychedelic & Consciousness Research announced in its Summer 2022 Newsletter a new study opportunity. Patients suffering from Post-Treatment Lyme Disease in the Baltimore area who continue […]
The Lyme Disease Association, Inc. is posting the following announcement for the CTN to clinicians, researchers & investigators from academic institutions. We are happy to announce that the Clinical Trials […]
Columbia CTN Announces 2nd Call: Treatment Research Ideas from Public, Clinicians, Others: Invitation to Participate: The Columbia Clinical Trails Newtwork Coordinating Center (CTNCC) welcomes input from the public, community clinicians, and […]
Heidi K. Goethert, et al., published, “Incrimination of shrews as a reservoir for Powassan virus,” in Communications Biology. The study examines Powassan virus lineage 2 (deer tick virus), and the growing threat the pathogen poses to American public health. Powassan virus is known to cause severe neurologic disease although its life cycle in nature is poorly understood.
Deadline Aug. 1 The Lyme Disease Association Inc. is notifying researchers that the Clinical Trials Network established with a grant from the Steven & Alexandra Cohen Foundation to Columbia […]
From Columbia Clinical Trials Network: In recognition of a severe unmet need, the Steven and Alexandra Cohen Foundation’s grant to Columbia University has established the first national Columbia Clinical Trials […]
LDA Doctor Referral System © Terms & Conditions and Guidelines
Save this Information for Your Records:
About LDA DOCTOR REFERRAL SYSTEM ©
Welcome to the Lyme Disease Association’s LDA Doctor Referral System ©. LDA made updates and enhancements to its prior system and has launched a new site to provide patients with information about doctors, other practitioners, testing labs, and pharmacies that are knowledgeable about chronic Lyme disease and often about many other tick-borne diseases (TBD). Many of the doctors listed are often referred to as Lyme Literate Physicians/Doctors (LLMD). Tens of thousands of patients have successfully used the prior LDA system to locate Lyme and TBD resources.
Terms & Conditions and Guidelines
Because there is a negative political climate surrounding Lyme disease, many LLMDs do not want their names posted outright on the internet. LDA has tried to balance the doctors’ wishes with patients’ need to find a doctor. This new system is a result of that compromise and therefore:
Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines, Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the LDA Doctor Referral System © contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the location entered and specaialty/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of so we can investigate.